Reumatologia 2014; 52/6
Review paper/Artykuł przeglądowy
Reumatologia 2014; 52, 6: 384–387
DOI: 10.5114/reum.2014.47232
IgG4-related disease and systemic vasculitis – is there
any connection?
Choroba IgG4-zależna aukładowe zapalenie naczyń – czy istnieje jakiś związek?
Anna Masiak, Zbigniew Zdrojewski
Department of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gdańsk
Key words: IgG4-related diseases, systemic vasculitis, ANCA antibody.
Słowa kluczowe: choroba IgG4-zależna, układowe zapalenie naczyń, przeciwciała ANCA.
Streszczenie
Choroby IgG4-zależne to stosunkowo nowa grupa schorzeń o nie-
wyjaśnionej dotychczas etiologii. Charakteryzują się one zwięk-
szonym stężeniem podklasy IgG4 immunoglobulin w surowicy
i naciekami tkankowymi z komórek IgG4-dodatnich z typowym
włóknieniem zajętych narządów. Zwiększone stężenie IgG4 może
występować w wielu innych chorobach przebiegających z przewle-
kłym stanem zapalnym. W ostatnich latach zwraca się uwagę, że
może to dotyczyć również chorych na układowe zapalenia naczyń,
szczególnie ANCA-dodatnie. Celem niniejszego opracowania jest
chęć zwrócenia uwagi na fakt, iż w niektórych przypadkach zarów-
no objawy kliniczne, jak i obraz histopatologiczny chorób IgG4-za-
leżnych i układowych zapaleń naczyń mogą być podobne. Znacze-
nie zwiększonego stężenia IgG4 u chorych z AAV (ANCA-associated
vasculitis)
jest niejasne i wymaga dalszych badań.
Address for correspondence:
Anna Masiak, MD, PhD, Department of Internal Medicine, Connective Tissue Diseases and Geriatrics, Medical University of Gdańsk,
Dębinki 7, 80-211 Gdańsk, e-mail: anna.masiak@wp.pl
Submitted: 18.08.2014
Summary
IgG4-related disease is a relatively new group of diseases of still
unknown etiology. It is characterized by elevated serum levels of
subclass IgG4 immunoglobulin and by abundant infiltration of
IgG4+ plasma cells with typical fibrosis of the affected organs. El-
evated concentration of IgG4 may be present in many other con-
ditions associated with chronic inflammation. In recent years, it is
noted that this may also apply to patients with systemic vasculitis,
in particular antineutrophil cytoplasmic antibody (ANCA)-associat-
ed vasculitis. The aim of this study is to draw attention to the fact
that in some cases, both clinical presentation and histopatholog-
ical findings in IgG4-related diseases and systemic vasculitis may
be similar. The importance of elevated serum IgG4 immunoglobulin
in patients with
ANCA-associated vasculitis (AAV) is unclear and
requires further research.
Introduction
IgG4-related disease (IgG4-RD) is a relatively new
and still not fully understood group of diseases [1, 2].
It is characterised by elevated serum concentrations of
the IgG4 subclass of immunoglobulins and typical histo-
pathological features (tissue infiltration by IgG4-positive
cells, a cartwheel-like pattern of fibrosis (storiform fibro-
sis), and obliterative phlebitis) [2–5].
The pathogenesis of the disease remains unclear.
Autoimmune and allergic factors are being considered
[6, 7]. The G4 subclass (IgG4) is the rarest of the immu-
noglobulin subclasses. Its structure and properties are
unique [8]. It possesses anti-inflammatory activity. The
IgG4 subclass is also the only subclass incapable of ac-
tivating the classic complement pathway. It does, how-
ever, display an ability to bind with the Fc fragment of
another IgG immunoglobulin. Mice models have demon-
strated that subclasses exhibiting no complement ac-
tivation ability may interact with other IgG antibody
subclasses and activate the complement system via the
lectin pathway [9]. What is known is that Th2-dependent
cytokine activity, such as interleukin 4, 5, 10 and 13 as
well as transforming growth factor β (TGF-β), elicits a re-
sponse in the form of eosinophilia, elevated concentra-
tions of IgG4 and IgE, and progressive fibrosis [8]. The
results of studies conducted to date have shown that
it is overexpression of Th2 and Treg lymphocytes and
their dependent cytokines that plays the main role in
the pathogenesis of IgG4-related disease [10–12]. These
Reumatologia 2014; 52/6
385
IgG4-related disease and systemic vasculitis – is there any connection?
cytokines, primarily interleukin (IL)-10, are responsible
for the appearance of allergic symptoms, eosinophilia
and elevated concentrations of IgE and IgG4 – typical
for IgG4-related disease [13].
IgG4-RD most commonly affects middle-aged and
elderly men (mean age – 65 years) [6, 14–16]. Onset
of the disease is usually sub-acute with an absence of
systemic symptoms, and diagnosis is often incidental.
The disease process usually involves multiple organs
and leads to progressive organ fibrosis and decreased
function. The most commonly affected sites are the pan-
creas, hepatic bile duct, salivary glands, soft tissues of
the orbital cavity, and lymph nodes. Less common sites
include the mediastinum, retroperitoneal space, soft tis-
sues, skin, central nervous system, thyroid, respiratory
tract, kidneys, prostate, and the mammary gland [2, 6].
Symptoms of the disease may present concurrently or
develop metachronously. Over time, usually after a pe-
riod of several years, the disease progresses to involve
new organs, and new symptoms appear. In 2012, Japa-
nese researchers proposed a set of criteria for the diag-
nosis of IgG4-related diseases (Table I) [6].
IgG4-related disease and vasculitis
Blood vessels of various calibre may also be af-
fected in the course of IgG4-related disease [5, 17, 18].
Clinical similarities between IgG4-related disease and
small-vessel vasculitis, particularly ANCA-positive vas-
culitis (ANCA-associated vasculitis – AAV]) are especial-
ly interesting [19]. Symptoms of asthma, involvement of
the paranasal sinuses, lungs, kidneys and peripheral eo-
sinophilia are common to both conditions. Publications
have described cases of IgG4-related disease with con-
comitant cutaneous leukocytoclastic vasculitis [20], He-
noch-Schönlein purpura [21], or allergic vasculitis with
hypocomplementaemia [22].
A noteworthy feature is that some patients with AAV
have elevated serum IgG4 concentrations and IgG4+ cell
infiltration of affected tissues. Elevated serum IgG4 sub-
class concentrations are present in most patients diag-
nosed with IgG4-related disease. It is worth bearing in
mind that physiological IgG4 responses may be initiated
by repeated exposure to an antigen, and elevated con-
centrations of IgG4 are also present in chronic inflam-
mation, neoplasms, autoimmune diseases, infections,
and vasculitis [23, 24].
Of 158 patients hospitalized at the Mayo Clinic, found
to have elevated serum IgG4 subclass concentrations
(> 140 mg/dl), only 29 patients (18.4%) fullfiled the crite-
ria for definite or probable IgG4-related disease. At the
same time, 9 patients (5.7%) were diagnosed with vas-
culitis, 5 of whom had granulomatosis with polyangiitis
(GPA), 3 had eosinophilic granulomatosis with polyangii-
tis (EGPA), and 1 patient had polyarteritis nodosa [25].
Similarly, a study conducted by a French centre showed
that only 10% of patients with elevated IgG4 concentra-
tions were diagnosed with IgG4-related disease. In this
study, 2 of the patients were diagnosed with vasculitis:
microscopic polyangiitis (MPA) and cryoglobulinaemia
in association with HCV infection [26]. A study by Car-
ruthers et al. determined that the negative predictive
value of an elevated IgG4 concentration was 96% and
the positive predictive value was 34% [27].
The largest number of reports of elevated serum IgG4
concentrations in patients with AAV concerns patients
diagnosed with EGPA [28, 29]. In a comparison of serum
IgG4 concentrations in patients with EGPA, GPA and atop-
ic asthma, Vaglio found that 75% of patients with active
EGPA had an elevated level of IgG4. Serum IgG4 levels
were significantly higher in patients with EGPA compared
to patients with GPA or asthma, and IgG4 concentra-
tions among patients with GPA were higher compared
to healthy individuals. In patients with EGPA, serum IgG4
concentration correlated with disease activity assessed
using the Birmingham Vasculitis Activity Score (BVAS),
the number of affected organs and risk factors assessed
by the Five Factors Score (FFS); at the same time, IgG4
levels declined during periods of remission [30]. Further
research is needed in order to confirm the usefulness of
repeated IgG4 determinations in monitoring therapy.
Histopathological features
A number of similarities between IgG4-related dis-
ease and AAV are also visible in microscopy images.
Abundant inflammatory cell infiltration, focal areas of
fibrosis and vascular lesions are characteristic morpho-
logical features of both conditions. This is particularly
evident in biopsy material from the head and neck ar-
Table I. Clinical diagnostic criteria for IgG4-related dis-
ease according to Umehara et al. [6]
1. Characteristic features of organ involvement in the
form of diffuse or nodular enlargement or abnor-
mal organ function
2. Elevated serum IgG4 concentration (≥ 135 mg/dl)
3. Histopathological abnormalities:
(A) lymphocyte and plasma cell infiltration and
fibrosis
(B) IgG4+ cell infiltration: > 10 IgG4+ cells per high
power field and IgG4+/IgG cell ratio > 40%
IgG4-related disease diagnosis:
Definite 1 + 2 + 3
Probable 1 + 3
Possible 1 + 2
Reumatologia 2014; 52/6
386
Anna Masiak, Zbigniew Zdrojewski
eas. Necrotizing vasculitis and granulomas, typical fea-
tures of AAV, are less common in these areas [31].
Researchers from the Mayo Clinic examined biopsy
material obtained from patients with GPA and deter-
mined that IgG4+ cell infiltration was present in over 18%
of these patients. An interesting point is that these infil-
trations were only present in bioptates obtained from the
upper respiratory tract and orbital tissues (38.1%). They
were not found in any other location or in any subject in
the control group [32]. From a clinical perspective, this is
a very significant observation, indicating that care must
be taken when interpreting the results of histopatholog-
ical examinations and their value in the context of the
complete clinical picture. Determining the exact signifi-
cance of IgG4+ cell infiltrates in the pathogenesis of GPA
will require further studies. Some authors have suggest-
ed that significantly increased infiltration at these sites
is linked to the intensity of inflammation [5]. Lacrimal
and salivary gland inflammation leads to the activation
of significant numbers of lymph nodules engaged in local
IgG4+ cell production. The most important features that
differentiate IgG4-related disease from ANCA-positive
vasculitis are presented in Table II.
ANCA antibody subclasses
Antineutrophil cytoplasmic antibodies (ANCA) typi-
cally belong to the IgG class. Brouwer was the first to
demonstrate that both PR3-ANCA and MPO-ANCA,
present in a group of patients with AAV, belonged pre-
dominantly to the IgG1 and IgG4 subclasses [33]. Many
researchers have suggested that a subclass of these
antibodies may be involved in the pathogenesis of AAV
[34]. Studies have also indicated that ANCA-IgG4 plays
an important role in GPA pathogenesis [35–37]. Ele-
vated titres of the MPO-IgG4 subclass in patients with
GPA may indicate repeated, chronic stimulation of the
immune system [36]. At the same time, many studies
have shown that the IgG3 subclass of PR3-ANCA is most
closely associated with active disease and renal involve-
ment [34, 35, 38]. However, defining the precise role of
the IgG4 subclass of ANCA in the pathogenesis of AAV
requires further research.
Conclusions
The association between IgG4-related disease and
systemic vasculitis remains unclear. EGPA would appear
to be the exception, where overexpression of Th2 lym-
phocytes and their related cytokines may explain the
pronounced IgG4 response. Further studies are required
to establish whether elevated IgG4 concentrations in in-
flammatory vascular disease play a significant role in its
pathogenesis or are merely an incidental finding. In clin-
ical practice, the possibility of clinical overlap of these
two conditions should be borne in mind.
The authors declare no conflict of interest.
References
1. Khosroshahi A, Stone JH. Aclinical overview of IgG4-related
systemic disease. Curr Opin Rheumatol 2011; 23: 57-66.
2. Stone JH, Khosroshahi A, Deshpande V, et al. Recommenda-
tions for the Nomenclature of IgG4-related disease and its in-
dividual organ system manifestations. Arthritis Rheum 2012;
64: 3061-3067.
3. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl
J Med 2012; 366: 539-551.
4. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on
the pathology of IgG4-related disease. Mod Pathol 2012; 25:
1181-1192.
5. Zen Y, Nakanuma Y. IgG4-related disease: across sectional
study of 114 cases. Am J Surg Pathol 2010; 34: 1812-1819.
6. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diag-
nostic criteria for IgG4-realted disease (IgG4-RD), 2011. Mod
Rheumatol 2012; 22: 21-30.
7. Sato Y, Notohara K, Kojima M, et al. IgG4-related disease: his-
torical overview and pathology of hematological disorders.
Pathol Int 2010; 60: 247-258.
8. Aalberse RC, Stapel SO, Schuurman J, Rispens T. Immunoglob-
ulin G4: an odd antibody. Clin Exp Allergy 2009; 39: 469-477.
9. Murata K, Fox-Talbot K, Qian Z, et al. Synergistic deposition of
C4d by complement-activating and non-activating antibodies
in cardiac transplants. Am J Transplant 2007; 7: 2605-2614.
10. Della Torre E, Mattoo H, Mahajan VS, et al. Prevalence of at-
opy, eosinophilia, and IgE elevation in IgG4-related disease.
Allergy 2014; 69: 269-272.
Table II. Differences between ANCA-positive vasculitis and IgG4-related disease (drawn up according to [19])
Differentiating feature IgG4-RD AAV
ANCA antibodies not found present
histopathological examination abnormalities Tissue infiltration by IgG4+ cells,
storiform fibrosis,
obliterative phlebitis
necrotizing small-vessel
vasculitis, granulomas
IgG4+ cell infiltration in affected organs/tissues > 50 cells per high power field varied, lower
IgG4+/IgG ratio > 40% varied, lower
Reumatologia 2014; 52/6
387
IgG4-related disease and systemic vasculitis – is there any connection?
11. Kanari H, Kagami S, Kashiwakuma D, et al. Role of Th2 cells
in IgG4-related lacrimal gland enlargement. Int Arch Allergy
Immunol 2010; 152 Suppl 1: 47-53.
12. Suzuki K, Tamaru J, Okuyama A, et al. IgG-4 positive multi-
organ lymphoproliferative syndrome manifesting as chronic
symmetrical sclerosing dacryo-sialadenitis with subsequent
secondary portal hypertension and remarkable IgG4-linked
IL-4 elevation. Rheumatology (Oxford) 2010; 49: 1789-1791.
13. Kamisawa T, Anjiki H, Egawa N, Kubota N. Allergic manifesta-
tions in autoimmune pancreatitis. Eur J Gastroenterol Hepatol
2009; 21: 1136-1139.
14. Kawano M, Saeki T, Nakashima H, et al. Proposal for diagnos-
tic criteria for IgG4-related kidney disease. Clin Exp Nephrol
2011; 15: 615-626.
15. Raissian Y, Nasr SH, Larsen CP, et al. Diagnosis of IgG4-related
tubulointerstitial nephritis. J Am Soc Nephrol 2011; 22: 1343-
1352.
16. Alexander MP, Larsen CP, Gibson IW, et al. Membranous glo-
merulonephritis is a manifestation of IgG4-related disease.
Kidney Int 2013; 83: 455-462.
17. Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as
manifestations of IgG4-related systemic disease. Curr Opin
Rheumatol 2011; 23: 88-94.
18. Kasashima S, Zen Y. IgG4-related inflammatory abdominal
aortic aneurysm. Curr Opin Rheumatol 2011; 23: 18-23.
19. Perez Alamino R, Martínez C, Espinoza LR. IgG4-associated
vasculitis. Curr Rheumatol Rep 2013; 15: 348.
20. Kawakami T, Yamaguchi N, Soma Y, et al. Immunoglobulin
G4-related disease associated with cutaneous vasculitis. Acta
Derm Venereol 2014; 94: 327-328.
21. Tamai R, Hasegawa Y, Hisano S, et al. Acase of IgG4-related
tubulointerstitial nephritis concurrent with Henoch-Schönlein
purpura nephritis. Allergy Asthma Clin Immunol 2011; 7: 5.
22. Wakamatsu R, Watanabe H, Suzuki K, et al. Hypocomplemen-
temic urticarial vasculitis syndrome is associated with high
levels of serum IgG4: a clinical manifestation that mimics
IgG4-related disease. Intern Med 2011; 50: 1109-1112.
23. Strehl JD, Hartmann A, Agaimy A. Numerous IgG4-positive
plasma cells are ubiquitous in diverse localised non-specif-
ic chronic inflammatory conditions and need to be distin-
guished from IgG4-related systemic disorders. J Clin Pathol
2011; 64: 237-243.
24. Yamamoto M, Tabeya T, Naishiro Y, et al. Value of serum IgG4
in the diagnosis of IgG4-related disease and in differentiation
from rheumatic diseases and other diseases. Mod Rheumatol
2012; 22: 419-425.
25. Ryu JH, Horie R, Sekiguchi H, et al. Spectrum of disorders as-
sociated with elevated serum IgG4 levels in clinical practice.
Int J Rheumatol 2012; 2012: 232960.
26. Ebbo M, Grados A, Bernit E, et al. Pathologies associated with
serum IgG4 elevation. Int J Rheumatol 2012; 2012: 602809.
27. Carruthers MN, Khosroshahi A, Augustin T, et al. The diag-
nostic utility of serum IgG4 concentrations in IgG4-related
disease. Ann Rheum Dis 2014, Mar 20 [Epub ahead of print].
28. Yamamoto M, Takahashi H, Suzuki C, et al. Analysis of serum
IgG subclasses in Churg-Strauss syndrome: the meaning of
elevated serum levels of IgG4. Intern Med 2010; 49: 1365-
1370.
29. Ayuzawa N, Ubara Y, Keiichi S, et al. Churg-Strauss syndrome
with a clinical condition similar to IgG4-related kidney dis-
ease: acase report. Intern Med 2012; 51: 1233-1238.
30. Vaglio A, Strehl JD, Manger B, et al. IgG4 immune response in
Churg-Strauss syndrome. Ann Rheum Dis 2012; 71: 390-393.
31. Devaney KO, Travis WD, Hoffman G, et al. Interpretation
of head and neck biopsies in Wegener’s granulomatosis.
Apathologic study of 126 biopsies in 70 patients. Am J Surg
Pathol 1990; 14: 555-564.
32. Chang SY, Keogh KA, Lewis JE, et al. IgG4-positive plasma cells
in granulomatosis with polyangiitis (Wegener’s): a clinico-
pathologic and immunohistochemical study on 43 granulo-
matosis with polyangiitis and 20 control cases. Hum Pathol
2013; 44: 2432-2437.
33. Brouwer E, Tervaert JW, Horst G, et al. Predominance of IgG1
and IgG4 subclasses of antineutrophil cytoplasmatic autoan-
tibodies (ANCA) in patients with Wegener’s granulomatosis
and clinically related disorders. Clin Exp Immunol 1991; 83:
379-386.
34. Colman R, Hussain A, Goodall M, et al. Chimeric antibodies
to proteinase 3 of IgG1 and IgG3 subclasses induce differ-
ent magnitudes of functional responses in neutrophils. Ann
Rheum Dis 2007; 66: 676-682.
35. Holland M, Hewins P, Goodall M, et al. Anti-neutrophil cyto-
plasm antibody IgG subclasses in Wegener’s granulomatosis:
apossible pathogenic role for the IgG4 subclass. Clin Exp Im-
munol 2004; 138: 183-192.
36. Liu LJ, Chen M, Yu F, et al. IgG subclass distribution, affinity of
anti-myeloperoxidase antibodies in sera from patients with
Wegener’s granulomatosis and microscopic polyangiitis. Ne-
phrology 2008; 13: 629-635.
37. Hussain A, Pankhurst T, Goodall M, et al. Chimeric IgG4
PR3-ANCA induces selective inflammatory responses from
neutrophils through engagement of Fc receptors. Immunol-
ogy 2009; 128: 236-244.
38. Pankhurst T, Nash G, Williams J, et al. Immunoglobulin sub-
class determines ability of immunoglobulin (Ig)G to capture
and activate neutrophils presented as normal human IgG
or disease-associated anti-neutrophil cytoplasm antibody
(ANCA)- IgG. Clin Exp Immunol 2011; 164: 218-226.